Lin Yang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Ejection Fraction

Peritoneal Dialysis

Small Cell Lung Cancer

Patient Reported

Top Venues

Thoracic cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Shuaibo Wang, Ye Li, Xujie Sun, Jiyan Dong, Li Liu, Jingbo Liu, Ruanqi Chen, Feng Li, Tiange Chen, Xiang Li, Guotong Xie, Jian-Ming Ying, Qiang Guo, Yousheng Mao, Lin Yang
Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system. Thoracic cancer (2024)
Shuaibo Wang, Ye Li, Xujie Sun, Jiyan Dong, Li Liu, Jingbo Liu, Ruanqi Chen, Feng Li, Tiange Chen, Xiang Li, Guotong Xie, Jian-Ming Ying, Qiang Guo, Yousheng Mao, Lin Yang
Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system. Thoracic cancer (2024)
Shuaibo Wang, Ye Li, Xujie Sun, Jiyan Dong, Li Liu, Jingbo Liu, Ruanqi Chen, Feng Li, Tiange Chen, Xiang Li, Guotong Xie, Jian-Ming Ying, Qiang Guo, Yousheng Mao, Lin Yang
Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system. Thoracic cancer 15 (7) (2024)
Shuaibo Wang, Ye Li, Xujie Sun, Jiyan Dong, Li Liu, Jingbo Liu, Ruanqi Chen, Feng Li, Tiange Chen, Xiang Li, Guotong Xie, Jian-Ming Ying, Qiang Guo, Yousheng Mao, Lin Yang
Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system. Thoracic cancer 15 (7) (2024)
Shuaibo Wang, Ye Li, Xujie Sun, Jiyan Dong, Li Liu, Jingbo Liu, Ruanqi Chen, Feng Li, Tiange Chen, Xiang Li, Guotong Xie, Jian-Ming Ying, Qiang Guo, Yousheng Mao, Lin Yang
Proposed novel grading system for stage I invasive lung adenocarcinoma and a comparison with the 2020 IASLC grading system. Thoracic cancer 15 (7) (2024)
Chunfang Hu, Jiyan Dong, Li Liu, Jingbo Liu, Xujie Sun, Fei Teng, Xin Wang, Jianming Ying, Junling Li, Pu-Yuan Xing, Lin Yang
ASCL1 and DLL3 expressions and their clinicopathological implications in surgically resected pure small cell lung cancer: A study of 247 cases from the National Cancer Center of China. Thoracic cancer 13 (3) (2021)